Syncom Formul.

{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "11.38",
    "chg": 0.14,
    "chgp": "1.25%",
    "dir": 1,
    "prev_price": "11.24",
    "mcapval": "1,069.72 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE312C01025",
    "curr_date": "Mar 24",
    "curr_time": "",
    "bse_nse_vol": "24.35 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 24, 2026",
    "traded_date_str": "2026 03 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syncom-formul-831770-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Markets Rally, But Syncom Formulations Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-of-rs1105-3910052",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_priceRelatedfactors_3910052.png",
        "date": "2026-03-24 10:07:46",
        "description": "While the broader market showed signs of recovery, Syncom Formulations (India) Ltd slipped to a fresh 52-week low of Rs 11.05 on 24 Mar 2026, extending a downward trajectory that has seen the stock lose nearly 38% over the past year."
      },
      {
        "title": "Why is Syncom Formulations (India) Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-syncom-formulations-india-ltd-fallingrising-3908863",
        "imagepath": "",
        "date": "2026-03-24 01:31:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Syncom Formulations hit a new 52-week low of ₹11.13 on the same day, signalling sustained selling pressure. The stock’s performance today lagged behind the Pharmaceuticals &amp; Drugs sector, which itself declined by 3.62%. This underperformance by approximately 1.18 percentage points highlights the stock’s vulnerability amid a broader sector downturn.</p>\n<p>Moreover, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Such a technical positioning often indicates a bearish trend, suggesting that investor sentiment remains subdued and that the stock is struggling to find short-term support levels.</p>\n<p><strong>Comparative Returns and Longer-Term Perspective</strong><..."
      },
      {
        "title": "Markets Rally, But Syncom Formulations (India) Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-of-rs1128-3907828",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_priceRelatedfactors_3907828.png",
        "date": "2026-03-23 12:30:14",
        "description": ""
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3892101",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_mojoScore_3892101.png",
        "date": "2026-03-15 10:10:23",
        "description": "Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3868918",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_mojoScore_3868918.png",
        "date": "2026-03-04 10:10:34",
        "description": "Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Syncom Formulations (India) Ltd Falls to 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-amid-continued-downtrend-3864816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_priceRelatedfactors_3864816.png",
        "date": "2026-03-02 12:27:13",
        "description": "Syncom Formulations (India) Ltd has touched a new 52-week low of Rs.11.36 today, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have underperformed both its sector and the broader market, reflecting persistent challenges in its financial performance and market positioning."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3849276",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyncomFormulati_mojoScore_3849276.png",
        "date": "2026-02-21 10:10:31",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Syncom Formulations Shares Shift to Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-shares-shift-to-bearish-momentum-amid-technical-downgrade-3847747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyncomFormulati_technicaldot_3847747.png",
        "date": "2026-02-20 08:03:24",
        "description": "Syncom Formulations (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The pharmaceutical company’s shares have declined by 4.04% recently, reflecting growing investor caution amid deteriorating technical parameters and a downgrade in its Mojo Grade from Hold to Sell."
      },
      {
        "title": "Syncom Formulations (India) Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3845079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyncomFormulati_technicaldot_3845079.png",
        "date": "2026-02-18 08:02:40",
        "description": "Syncom Formulations (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a modest daily gain of 1.03%, the stock’s overall technical profile remains cautious, reflecting mixed signals from MACD, RSI, moving averages, and other momentum oscillators. Investors in the Pharmaceuticals & Biotechnology sector should carefully analyse these developments as the stock navigates a challenging market environment."
      }
    ],
    "total": 261,
    "sid": "831770",
    "stock_news_url": "https://www.marketsmojo.com/news/syncom-formulations-india-831770"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Feb-2026",
      "details": "Submission of Press Clipping Related to extract of Un-Audited Financial Result for the Quarter and Nine months ended on 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Regulation 33(3) Of SEBI (LODR) Regulations 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review Report For The Quarter And Nine Months Ended On 31St December 2025",
      "datetime": "12-Feb-2026",
      "details": "Submission of Unaudited standalone and Consolidated Financials as an outcome of Board meeting held on 12th February 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Holding 5/2025-26 Board Meeting For Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 31St December 2025.",
      "datetime": "04-Feb-2026",
      "details": "Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 5/2025-26 Meeting of the Board of Directors of the Company is scheduled to be held on Thursday the 12th day of February 2026 at 3:00 P.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>3%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Markets Rally, But Syncom Formulations Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-24 10:07:46

While the broader market showed signs of recovery, Syncom Formulations (India) Ltd slipped to a fresh 52-week low of Rs 11.05 on 24 Mar 2026, extending a downward trajectory that has seen the stock lose nearly 38% over the past year.

Read full news article

Why is Syncom Formulations (India) Ltd falling/rising?

2026-03-24 01:31:11

Recent Price Movement and Market Context

Syncom Formulations hit a new 52-week low of ₹11.13 on the same day, signalling sustained selling pressure. The stock’s performance today lagged behind the Pharmaceuticals & Drugs sector, which itself declined by 3.62%. This underperformance by approximately 1.18 percentage points highlights the stock’s vulnerability amid a broader sector downturn.

Moreover, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Such a technical positioning often indicates a bearish trend, suggesting that investor sentiment remains subdued and that the stock is struggling to find short-term support levels.

Comparative Returns and Longer-Term Perspective<...

Read full news article

Markets Rally, But Syncom Formulations (India) Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-23 12:30:14

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-03-15 10:10:23

Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-03-04 10:10:34

Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Syncom Formulations (India) Ltd Falls to 52-Week Low Amid Continued Downtrend

2026-03-02 12:27:13

Syncom Formulations (India) Ltd has touched a new 52-week low of Rs.11.36 today, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have underperformed both its sector and the broader market, reflecting persistent challenges in its financial performance and market positioning.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-02-21 10:10:31

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Read full news article

Syncom Formulations Shares Shift to Bearish Momentum Amid Technical Downgrade

2026-02-20 08:03:24

Syncom Formulations (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The pharmaceutical company’s shares have declined by 4.04% recently, reflecting growing investor caution amid deteriorating technical parameters and a downgrade in its Mojo Grade from Hold to Sell.

Read full news article

Syncom Formulations (India) Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

2026-02-18 08:02:40

Syncom Formulations (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a modest daily gain of 1.03%, the stock’s overall technical profile remains cautious, reflecting mixed signals from MACD, RSI, moving averages, and other momentum oscillators. Investors in the Pharmaceuticals & Biotechnology sector should carefully analyse these developments as the stock navigates a challenging market environment.

Read full news article

View All News